Bisfosfonatos orales y alteraciones musculares esqueléticas

González-Ruiz, Mario; Encarnación González-Ruiz, Mercedes; Villota Hoyos, Rosario; Rodríguez Muriedas, Pilar.
Aten. prim. (Barc., Ed. impr.) ; 38(3): 184-185, jul. 2006. tab
Artículo en Es | IBECS (España) | ID: ibc-051477

Documentos relacionados

  1. Cabozantinib-induced serum creatine kinase elevation and musculoskeletal complaints.
  2. Bisphosphonates: bone, muscle and joint pain.
  3. Analysis of different therapeutic protocols for osteonecrosis of the jaw associated with oral and intravenous bisphosphonates.
  4. [Oral bisphosphonates and musculoskeletal disorders].
  5. Scleritis and Intraorbital Inflammation following Oral and Intravenous Bisphosphonates in a 66-Year-Old Man.
  6. Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
  7. Effect of oral zoledronate administration on bone turnover in older women.
  8. The ocular findings related to oral bisphosphonate use.
  9. An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
  10. Oral bisphosphonates-associated osteonecrosis in rheumatoid arthritis.